News
A recent study showed that well-known diabetes and weight loss drugs such as Ozempic and Wegovy do not raise the risk of ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
There are plenty of people taking Ozempic to lose weight, but Doctor Giles Yeo has explained the main problem people have ...
Sharon Osbourne previously opened up about a worrying ‘side effect’ she had suffered after using Ozempic. The former The X ...
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
What are the most concerning consequences of the drug and other weight-loss medicines? - Gastrointestinal and cardiovascular ...
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug ...
A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
FAT jabs like Mounjaro and Wegovy could slash boozing by two-thirds, a study has shown. It’s not the first time the weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results